.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
UBS
Mallinckrodt
McKesson
Dow
Argus Health
Covington
Johnson and Johnson
Merck
Novartis

Generated: June 27, 2017

DrugPatentWatch Database Preview

Ethopropazine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ethopropazine hydrochloride and what is the scope of ethopropazine hydrochloride patent protection?

Ethopropazine hydrochloride
is the generic ingredient in one branded drug marketed by Parke Davis and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for ethopropazine hydrochloride.

Summary for Generic Name: ethopropazine hydrochloride

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list1
Bulk Api Vendors: see list16
Clinical Trials: see list2,244
Patent Applications: see list296
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ethopropazine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
PARSIDOL
ethopropazine hydrochloride
TABLET;ORAL009078-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Parke Davis
PARSIDOL
ethopropazine hydrochloride
TABLET;ORAL009078-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Parke Davis
PARSIDOL
ethopropazine hydrochloride
TABLET;ORAL009078-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Medtronic
Merck
UBS
Citi
Harvard Business School
Express Scripts
Accenture
Baxter
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot